Last Updated : Friday, July 3, 2020 17:06:02

News of Ahmedabad in Gujarat

RIL’s JIO Platforms sells 0.39% stake to INTEL CAPITAL for 19 bln INR

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mukesh Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of Intel Capital, investment arm of Intel Corporation having invested 19 billion (~1,894.50 crore) rupees in Jio Platforms inturn acquiring 0.39% equity stake in the Jio

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

ARVIND FASHIONS to raise 4 billion (~400 Cr) rupees via Rights Issue

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ahmedabad headquartered textiles and apparels Indian major Arvind Ltd’s fashion arm Arvind Fashions Ltd said of its intent to raise 4 billion (~399.79 crore) rupees via Rights Issue. In a press-release titled, “Arvind Fashions Limited to raise up

SAUDI ARABIAN money pours in RIL’s JIO, buys 2.32% stake paying 114 bln INR

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mukesh Dhirubhai Ambani led Diversified Indian Conglomerate – Reliance Group’s flagship company Reliance Industries Ltd said of public investment fund (PIF) having invested 113.67 billion (~11,367 crore) rupees in Jio Platforms Ltd acquiring 2.32% equity stake on fully diluted basis

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

CADILA HEALTH ink pact with GILEAD SCIENCES to mfr & mkt REMDESIVIR

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges from Ahmedabad headquartered Pankaj Patel led Zydus Group’s Healthcare Services providing, Pharmaceutical and Wellness products manufacturing Indian company Cadila Healthcare Ltd it said of having inked non-exclusive licensing agreement with Gilead Sciences Inc., to manufacture and market Remdesivir

LUPIN gets USFDA nod to sell medicine to treat liver, lung disorders

BALTIMORE (US) / MUMBAI / RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company Lupin Ltd said of having got USFDA (US Food & Drugs Administration) nod to treat liver and lung disorders. In a press-release titled, “Lupin Receives Approval for Albendazole Tablets USP”, as

RADIO City becomes No.1 Radio Station in Mumbai, Delhi, Bengaluru

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered Broadcasting & Cable TV sector company Music Broadcast Ltd said of its flagship FM Radio brand Radio City having created history, the FM services ranked as number one radio station in Mumbai, Delhi and Bengaluru, as per the

ARVIND partners with Swiss and Taiwanese entities, launches anti-viral fabric

ZURICH (SWITZERLAND) / AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ahmedabad headquartered textiles and apparels manufacturing Indian company Arvind Ltd announced launch of anti-viral fabrics under its Intellifabrix brand, the company has partnered with Swiss Textiles innovator HeiQ to introduce HeiQ Viroblock technology in India

ADANI bags $6 bln (~45k Cr INR) solar project from SOLAR ENERGY CORP

DALLAS / BRISBANE / AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Gautam Adani led Diversified Indian Conglomerate Adani Group’s green energy arm Adani Green Energy Ltd said of having won world’s largest and first of its kind of single investment solar manufacturing linked

USFDA grants Orphan Drug Status for medicine to treat neuromascular disorders

ZUG (SWITZERLAND) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Pharmaceutical products manufacturing Indian company Lupin Ltd said of USFDA having granted one of the medicine to treat neuro-mascular disorders as orphan drug designation. Orphan drug designation allows companies an exclusive marketing, and development rights

ABU DHABI INV AUTHORITY buys 1.16% stake in RIL’s JIO paying 57 bln INR

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Mukesh Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of Abu Dhabi Investment Authority (ADIA) having invested 57 billion (~5,683.50 crore) rupees in the company’s data & telecom arm – Jio Platforms Ltd.

SILVER LAKE & Co-Investors buy addl 2.08% stake in (RIL’s) JIO Platforms

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered Mukesh Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of Silver Lake and co-investors to buy additional 2.08% stake in JIO Platforms Ltd, paying 46 billion (~4,546.80 crore) rupees. In a press-release titled,

(ZYDUS) CADILA HEALTH gets USFDA nod to sell medicine to treat HIV

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led healthcare services providing and pharmaceutical as well as wellness products manufacturing group Zydus Cadila’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell

MUBADALA (Abu Dhabi) buys 1.85% stake in (RIL’s) JIO Platform, for 91 bln INR

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Mukesh Dhirubhai Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of having bagged 91 billion (~9,093.60 crore) rupees investment in telecom-data & information technology arm of the company Jio Platforms Ltd. In a

RIL’s 531 bln rupees Rights Issue get subscribed 1.59 Times @ 840 bln rupees

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Mukesh Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of having received overwhelming response to the company’s rights issue of 531.24 billion (~53,124.20 crore) rupees, which was offered to existing shareholders, which got

Do NOT follow this link or you will be banned from the site!